NCT03364348
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Clinical trial condition
Stage IV Breast Cancer
Explore clinical trials studying Stage IV Breast Cancer. Study availability and eligibility vary by location and protocol.
141 public trials
3 recruiting studies
Stage IV Breast Cancer trial results
Completed
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
NCT02120469
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +9 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States
- South Pasadena Cancer Center South Pasadena, California, United States
Completed
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
NCT02536794
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +8 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States
NCT01987726
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +22 more
- Locations
-
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT03112668
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +80 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT03222258
- Conditions
- Biliary Cancer Metastatic, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
- Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
Completed
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +11 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT01908101
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
- Bozeman Deaconess Hospital Bozeman, Montana, United States
Completed
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
NCT02038010
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States